PubRank

M N Potter

Author PubWeight™ 31.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A laboratory comparison of T cell depletion by CD34+ cell immunoaffinity selection and in vitro Campath-1M treatment: clinical implications for bone marrow transplantation and donor leukocyte therapy. Bone Marrow Transplant 1997 1.96
2 Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis. Br J Haematol 1999 1.13
3 Transient erythroblastopenia of childhood with CD10, TdT, and cytoplasmic mu lymphocyte positivity in bone marrow. J Clin Pathol 1990 1.08
4 Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation. Bone Marrow Transplant 1998 0.92
5 Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant. Br J Haematol 2001 0.92
6 An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. Bone Marrow Transplant 2009 0.92
7 A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia. Blood 1994 0.87
8 Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion. Cytotherapy 2001 0.86
9 The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study. Bone Marrow Transplant 2011 0.86
10 Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol 1996 0.85
11 Unrelated donor bone marrow transplantation in children and young adults with acute myeloid leukaemia in remission. Br J Haematol 1997 0.84
12 Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation. Tissue Antigens 2004 0.84
13 Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy. Gene Ther 2002 0.84
14 Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia. Br J Haematol 1998 0.83
15 An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation. Cytotherapy 2000 0.83
16 Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD. Bone Marrow Transplant 2011 0.82
17 Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy. J Antimicrob Chemother 1990 0.82
18 The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation. Bone Marrow Transplant 2003 0.82
19 Immune reconstitution after BMT in children. Bone Marrow Transplant 1993 0.81
20 Novel approaches to transplant conditioning. Hematol Oncol 2001 0.81
21 Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia. Br J Haematol 1998 0.80
22 The use of a national transplant registry to benchmark transplant outcome for patients undergoing autologous and allogeneic stem cell transplantation in the United Kingdom and Ireland. Br J Haematol 2004 0.80
23 Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms. Bone Marrow Transplant 2009 0.78
24 Third complementarity determining region (CDR III) sequence analysis in childhood B-lineage acute lymphoblastic leukaemia: implications for the design of oligonucleotide probes for use in monitoring minimal residual disease. Leukemia 1992 0.78
25 A dedicated GvHD clinic may improve the quality of life for allogeneic stem cell transplant survivors. Clin Transplant 2012 0.77
26 Bone marrow transplantation from volunteer unrelated donors. Cancer Treat Rev 1995 0.77
27 Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin. Clin Transplant 2011 0.77
28 Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study. Bone Marrow Transplant 2013 0.77
29 Eosinophilic leukaemia with an abnormality of 5q31, the site of the IL-5 gene. Clin Lab Haematol 1991 0.77
30 Matched and mismatched unrelated donor bone marrow transplantation for juvenile chronic myeloid leukaemia. Br J Haematol 1996 0.77
31 Comparison of fluorescent consensus IgH PCR and allele-specific oligonucleotide probing in the detection of minimal residual disease in childhood ALL. Br J Haematol 1997 0.77
32 The study of minimal residual disease in acute lymphoblastic leukaemia. Clin Mol Pathol 1995 0.77
33 The use of the polymerase chain reaction to detect minimal residual disease in childhood acute lymphoblastic leukaemia. Eur J Cancer 1993 0.76
34 Faster engraftment of peripheral blood progenitor cells compared to bone marrow from unrelated donors. Bone Marrow Transplant 1998 0.76
35 Aspergillus appendicitis in acute myeloid leukaemia. Clin Lab Haematol 1990 0.76
36 Clonal instability in early B-lineage acute lymphoblastic leukemia. Blood 1992 0.75
37 Effects of haemopoietic growth factors for aplastic anaemia. Lancet 1994 0.75
38 Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M; effect on CD34+ cells and progenitor cell recoveries. Bone Marrow Transplant 1998 0.75
39 Transplantation of peripheral blood progenitor cells from unrelated donors. Bone Marrow Transplant 1996 0.75
40 Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukaemia of precursor B-cell origin. Leukemia 1992 0.75
41 The role of plasma exchange for TTP/HUS post-bone marrow transplant. Bone Marrow Transplant 1996 0.75
42 Solid-phase sequencing of multiple PCR products resolved by polyacrylamide gel electrophoresis. Biotechniques 1995 0.75
43 Same-day determination of chimaeric status in the immediate period following allogeneic bone marrow transplantation. Br J Haematol 1997 0.75
44 Unrelated donor bone marrow transplant in childhood ALL. The role of T-cell depletion. Bone Marrow Transplant 1996 0.75
45 Granulocyte-macrophage colony-stimulating factor (GM-CSF), hypocalcemia, and hypomagnesemia. Ann Intern Med 1990 0.75
46 False-positive residual disease assessment after bone marrow transplant in acute lymphoblastic leukemia. Blood 1994 0.75